FDA has proposed a rule to streamline registration for certain distributed drug manufacturing sites and clarify reporting requirements for some foreign production facilities, as part of its efforts ...
GlobalData on MSN
“Hub-and-spoke” drug manufacturing set to benefit from new FDA ruleThe proposed rule would allow multiple manufacturing units at different locations to register as one establishment.
In the wake of the Food & Drug Administration’s (FDA) ambitious unified agenda, on July 13, 2026, the agency published a proposed rule aiming to align its regulatory frameworks with “how distributed ...
Silver Spring, MD, July 10, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for ...
US FDA proposes a new rule to simplify drug manufacturer registration, improve supply chain transparency and strengthen oversight of global pharmaceutical networks.
On July 13, the US Food and Drug Administration (FDA) proposed a new rule that would fundamentally change how certain drug manufacturers ...
The US Food and Drug Administration (FDA) on Friday outlined a set of proposed reforms to advance modern manufacturing methods and increase supply chain visibility. In a proposed rule, the agency said ...
The FDA's new website and regulatory overhaul aim to close a loophole that lets foreign factories hide raw drug materials from U.S. supply chain oversight.
July 10 (Reuters) - The U.S. FDA on Friday proposed a rule to streamline registration requirements for certain drug manufacturers that operate through a central hub and multiple production facilities, ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly July 10 (Reuters) - The U.S. FDA has proposed a rule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results